Stock TBIO TELESIS BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Telesis Bio, Inc.

Equities

TBIO

US1920032000

Delayed Nasdaq
Other stock markets
 21:00:00 18/06/2024 BST 		5-day change 1st Jan Change
3.79 USD +2.16% Intraday chart for Telesis Bio, Inc. +20.32% -47.23%
05-09 Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M MT
05-09 Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
KeyBanc Downgrades Telesis Bio to Sector Weight From Overweight, Cites 'Limited Top-Line Visibility' Amid 'Tepid Biopharma Spending Environment'
MT
KeyBanc Capital Markets Adjusts Price Target on Codex DNA to $5 From $8, Maintains Overweight Rating
MT
KeyBanc Adjusts Codex DNA's Price Target to $8 From $30, Keeps Overweight Rating
MT
CODEX DNA : Cowen Starts Codex DNA at Outperform
MT
CODEX DNA : Jefferies Starts Codex DNA at Buy With $23 Price Target
MT
CODEX DNA : KeyBanc Starts Codex DNA at Overweight With $30 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Telesis Bio, Inc.
  5. Analyst Reco.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW